The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Business
•
July 19, 2026
•
2 Views
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
Source: https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Because adventure is exploring the unknown"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Commision Art Work or Just pure Beauty."